Carterra LSAXT Platform

Carterra LSAXT Platform

Disruptive Technology for Screening and Characterization

Drug Development Data Quality

Do you know anyone using Carterra LSAXT Platform?

The proprietary Carterra LSAXT HT-SPR technology platform expands beyond antibody discovery to enable PROTAC®s , protein-protein inhibitors, kinase, and cytokine screening and characterization. Enhanced sensitivity and fast data collection rate build upon unmatched capabilities in throughput and enable assays such as TPDs PROTAC®s , kinase, cytokines, DELs, and protein:protein inhibitors.

Carterra LSAXT Platform

Medigy Innovation Network

Connecting innovation decision makers to authoritative information, institutions, people and insights.

Medigy Logo

The latest News, Insights & Events

Medigy accurately delivers healthcare and technology information, news and insight from around the world.

The best products, services & solutions

Medigy surfaces the world's best crowdsourced health tech offerings with social interactions and peer reviews.


© 2025 Netspective Foundation, Inc. All Rights Reserved.

Built on Apr 30, 2025 at 4:13am